Where to buy Ruxolitinib tablets

Ruxolitinib is used to treat myelofibrosis (a bone marrow cancer in which the bone marrow is replaced by scar tissue and results in decreased blood cell production) and polycythemia vera (PV; a slow-growing blood cancer in which the bone marrow produces too many red blood cells). Ruxolitinib tabletsbelong to the kinase inhibitor class of drugs, which treat myelofibrosis andPV by blocking the signals that cause cancer cells to multiply.

Ruxolitinib tablets treat acute graft-versus-host disease (GVHD) by blocking the cell signals that trigger hematopoietic stem cell transplantation, which usually occurs in the first few months after HSCT in adults and children 12 and older who have not responded to treatment with steroid drugs. Children 12 years and older,It can also be used to treat chronicGVHD, which usually occurs at least 3 months after HSCT and occurs in adults and children 12 years and older and has not been treated with 1 or 2 other treatments.

Ruxolitinib tabletsThe original drug has been launched in China and is included in the scope of Class B medical insurance. It is limited to patients who meet the indications. SpecificationThe price of each box of 5mg*60 tablets may be around RMB 3,000. This drug may be sold in domestic pharmacies or hospitals. The Turkish version of ruxolitinib tablets listed overseas, Specifications20mg*56 tablets, may be priced around RMB 8,000 per box (the price may fluctuate due to exchange rates). There are also generic drugs of ruxolitinib tablets produced in other countries, such as those produced by Yaopin International in Bangladesh. The price of each box of 5mg*50 tablets may be around 1,400 yuan (the price may fluctuate due to the exchange rate). Its drug ingredients are basically the same as those of domestic and foreign original drugs. Overseas drugs need to be purchased through formal channels. For specific prices and drug details, please consult Yaode Medical Consultants.